These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019 [TBL] [Abstract][Full Text] [Related]
3. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Bittl JA; Baber U; Bradley SM; Wijeysundera DN J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919 [TBL] [Abstract][Full Text] [Related]
4. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Steg PG; Wiviott SD; Mauri L; J Am Coll Cardiol; 2016 May; 67(21):2492-502. PubMed ID: 27046159 [TBL] [Abstract][Full Text] [Related]
5. Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials. Fanari Z; Malodiya A; Weiss SA; Hammami S; Kolm P; Weintraub WS Cardiovasc Revasc Med; 2017; 18(1):10-15. PubMed ID: 27477306 [TBL] [Abstract][Full Text] [Related]
7. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials. Ziada KM; Abdel-Latif AK; Charnigo R; Moliterno DJ Catheter Cardiovasc Interv; 2016 Mar; 87(4):722-732. PubMed ID: 26309050 [TBL] [Abstract][Full Text] [Related]
8. Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial. Gargiulo G; Ariotti S; Santucci A; Piccolo R; Baldo A; Franzone A; Magnani G; Marino M; Esposito G; Windecker S; Valgimigli M JACC Cardiovasc Interv; 2016 Sep; 9(17):1780-9. PubMed ID: 27544007 [TBL] [Abstract][Full Text] [Related]
9. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease. Carrero JJ; Varenhorst C; Jensevik K; Szummer K; Lagerqvist B; Evans M; Spaak J; Held C; James S; Jernberg T Kidney Int; 2017 Jan; 91(1):216-226. PubMed ID: 27865441 [TBL] [Abstract][Full Text] [Related]
11. Long (>12 Months) and Short (<6 Months) Versus Standard Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Systematic Review and Meta-Analysis. Palla M; Briasoulis A; Siddiqui F; Alesh I; Afonso L Am J Ther; 2017; 24(4):e468-e476. PubMed ID: 26270798 [TBL] [Abstract][Full Text] [Related]
15. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials. Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419 [TBL] [Abstract][Full Text] [Related]
16. Development of a risk score for predicting the benefit versus harm of extending dual antiplatelet therapy beyond 6 months following percutaneous coronary intervention for stable coronary artery disease. Witberg G; Plakht Y; Bental T; Feldman BS; Leventer-Roberts M; Levi A; Gabay H; Balicer R; Gerber Y; Kornowski R PLoS One; 2019; 14(2):e0209661. PubMed ID: 30763340 [TBL] [Abstract][Full Text] [Related]
17. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Costa F; van Klaveren D; James S; Heg D; Räber L; Feres F; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Zanchin T; Palmerini T; Wallentin L; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M; Lancet; 2017 Mar; 389(10073):1025-1034. PubMed ID: 28290994 [TBL] [Abstract][Full Text] [Related]
18. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome. Paravattil B; Elewa H J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584 [TBL] [Abstract][Full Text] [Related]